Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Mark Botham is a staff cardiac surgeon with the Cleveland Clinic Foundation and Director of the Division of Thoracic and Cardiovascular surgery at Hillcrest Hospital. He is a Clinical Assistant Professor of Surgery at Case Western Reserve University
Dr. Botham has a special interest in acquired adult coronary disease and reconstructive valvular heart disease. He is certified by the American Board of Surgery and the American Board of Thoracic Surgery.
Dr. Botham was Phi Betta Kappa at the University of Wisconsin where he graduated with Honors and an undergraduate degree in biochemistry. He received his medical degree from Cornell University Medical School and completed his clinical training at the University of Michigan Medical Center where he was awarded a fellowship in thoracic surgery. He received research appointments at the University of Wisconsin in pathology and at the University of Michigan in thoracic surgery.
He has published articles in professional journals on topics such as primary cardiac lymphoma and production of human growth factor in saphenous vein and internal mammary artery segments in organ culture.
Dr. Botham is a Fellow in the American College of Chest Physicians, the American College of Cardiology, and the American College of Surgeons. In addition, he is a member of the American Medical Association, the John Alexander Society, the Frederick A. Coller Surgical Society, and the Society of Thoracic Surgeons.
Cardiac Surgery, Acquired Adult Cardiac Disease, Atrial Fibrillation, Heart Valve Disease, Mitral Valve Prolapse, Mitral Valve Stenosis , Thoracic Aortic Aneurysm, Ventricular Septal Defects
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/2/2014, Dr. Botham has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.